References
- World Health Organization. Global status report on alcohol and health. 2014.
- Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol. 59:160–68. 2013 Jul 1 [accessed 2019 Feb 27]. http://www.ncbi.nlm.nih.gov/pubmed/23511777.
- Mathurin P, Bataller R. Trends in the management and burden of alcoholic liver disease. J Hepatol. 62:S38. 2015 Apr [accessed 2019 Feb 27]. http://www.ncbi.nlm.nih.gov/pubmed/25920088.
- Leclercq S, de Timary P, Delzenne NM, Stärkel P. The link between inflammation, bugs, the intestine and the brain in alcohol dependence. Transl Psychiatry. 7:e1048–e1048. 2017 Feb 28 [accessed 2018 Dec 19]. http://www.ncbi.nlm.nih.gov/pubmed/28244981.
- Ferrere G, Wrzosek L, Cailleux F, Turpin W, Puchois V, Spatz M, Ciocan D, Rainteau D, Humbert L, Hugot C, et al. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice. J Hepatol. 2017 Apr;66:806–15. doi:10.1016/j.jhep.2016.11.008.
- Xu Z, Liu Z, Dong X, Hu T, Wang L, Li J, Liu X, Sun J. Fecal microbiota transplantation from healthy donors reduced alcohol-induced anxiety and depression in an animal model of chronic alcohol exposure. Chin J Physiol. 2018 Dec;61:360–71.
- Philips CA, Phadke N, Ganesan K, Ranade S, Augustine P. Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis. Indian J Gastroenterol. 2018 Jun;37:215–25. doi:10.1007/s12664-018-0859-4.
- Roychowdhury S, Glueck B, Han Y, Mohammad MA, Cresci GAM. A designer synbiotic attenuates chronic-binge ethanol-induced gut-liver injury in mice. Nutrients. 2019 Jan;11:97. doi:10.3390/nu11010097.
- Yang X, He F, Zhang Y, Xue J, Li K, Zhang X, Zhu L, Wang Z, Wang H, Yang S. Inulin ameliorates alcoholic liver disease via suppressing LPS-TLR4-Mpsi axis and modulating gut microbiota in mice. Alcohol Clin Exp Res. 2019 Mar 1;43:411–24.
- Sarin SK, Pande A, Schnabl B. Microbiome as a therapeutic target in alcohol-related liver disease. J Hepatol. 70:260–72. 2019 Feb [accessed 2019 Aug 23]. http://www.ncbi.nlm.nih.gov/pubmed/30658727.
- Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 339:b2700. 2009 Jul 21 [accessed 2019 Feb 27]. http://www.ncbi.nlm.nih.gov/pubmed/19622552.
- Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. Diversity of the human intestinal microbial flora. Science. 308:1635–38. 2005 Jun 10 [accessed 2019 Mar 4]. http://www.ncbi.nlm.nih.gov/pubmed/15831718.
- Wells G, Shea B, Robertson J, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. [accessed 2019 May 12]. http://www.evidencebasedpublichealth.de/download/Newcastle_Ottowa_Scale_Pope_Bruce.pdf.
- Amitay EL, Krilaviciute A, Brenner H. Systematic review: gut microbiota in fecal samples and detection of colorectal neoplasms. Gut Microbes. 1–15. 2018 Mar 15 [accessed 2019 May 12]. https://www.tandfonline.com/doi/full/10.1080/19490976.2018.1445957.
- Goodrich JK, Di Rienzi SC, Poole AC, Koren O, Walters WA, Caporaso JG, Knight R, Ley R. Conducting a microbiome study. Cell. 158:250–62. 2014 Jul 17 [accessed 2019 May 24]. http://www.ncbi.nlm.nih.gov/pubmed/25036628.
- Banan A, Keshavarzian A, Zhang L, Shaikh M, Forsyth CB, Tang Y, Fields JZ. NF-kappaB activation as a key mechanism in ethanol-induced disruption of the F-actin cytoskeleton and monolayer barrier integrity in intestinal epithelium. Alcohol. 41:447–60. 2007 Sep [accessed 2019 Feb 20]. https://linkinghub.elsevier.com/retrieve/pii/S0741832907001279.
- Leclercq S, Matamoros S, Cani PD, Neyrinck AM, Jamar F, Stärkel P, Windey K, Tremaroli V, Bäckhed F, Verbeke K, et al. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci USA. 111:E4485–93. 2014 Oct 21 [accessed 2019 Feb 4]. http://www.ncbi.nlm.nih.gov/pubmed/25288760.
- Chen Y, Yang F, Lu H, Wang B, Chen Y, Lei D, Wang Y, Zhu B, Li L. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology. 54:562–72. 2011 Aug 1 [accessed 2019 Feb 25]. http://doi.wiley.com/10.1002/hep.24423.
- Hillman ET, Lu H, Yao T, Nakatsu CH. Microbial ecology along the gastrointestinal tract. Microbes Environ. 32:300–13. 2017 Dec 27 [accessed 2019 Mar 5]. http://www.ncbi.nlm.nih.gov/pubmed/29129876.
- Bajaj JS, Kakiyama G, Zhao D, Takei H, Fagan A, Hylemon P, Zhou H, Pandak WM, Nittono H, Fiehn O, et al. Continued alcohol misuse in human cirrhosis is associated with an impaired gut-liver axis. Alcohol Clin Exp Res. 2017 Nov;41:1857–65. doi:10.1111/acer.13476.
- Zheng J, Yuan X, Zhang C, Jia P, Jiao S, Zhao X, Yin H, Du Y, Liu H. N-acetylcysteine alleviates gut dysbiosis and glucose metabolic disorder in high-fat diet-fed mice. J Diabetes. 11:32–45. 2019 Jan [accessed 2019 Mar 3]. http://doi.wiley.com/10.1111/1753-0407.12795.
- Watt E, Gemmell MR, Berry S, Glaire M, Farquharson F, Louis P, Murray GI, El-Omar E, Hold GL. Extending colonic mucosal microbiome analysis-assessment of colonic lavage as a proxy for endoscopic colonic biopsies. Microbiome. 2016 Nov 25;4:61. doi:10.1186/s40168-016-0207-9.
- Kakiyama G, Hylemon PB, Zhou H, Pandak WM, Heuman DM, Kang DJ, Takei H, Nittono H, Ridlon JM, Fuchs M, et al. Colonic inflammation and secondary bile acids in alcoholic cirrhosis. Am J Physiol Gastrointest Liver Physiol. 2014 Jun;306:G929–37.
- Llopis M, Cassard AM, Wrzosek L, Boschat L, Bruneau A, Ferrere G, Puchois V, Martin JC, Lepage P, Le Roy T, et al. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease. Gut. 65:830–39. 2016 May [accessed 2019 Feb 25]. http://www.ncbi.nlm.nih.gov/pubmed/26642859.
- Ciocan D, Rebours V, Voican CS, Wrzosek L, Puchois V, Cassard AM, Perlemuter G. Characterization of intestinal microbiota in alcoholic patients with and without alcoholic hepatitis or chronic alcoholic pancreatitis. Sci Rep. 2018 Dec 1;8. doi:10.1038/s41598-018-23146-3.
- Bajaj JS, Heuman DM, Hylemon PB, Sanyal AJ, White MB, Monteith P, Noble NA, Unser AB, Daita K, Fisher AR, et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol. 60:940–47. 2014 May [accessed 2019 Feb 25]. http://www.ncbi.nlm.nih.gov/pubmed/24374295.
- Puri P, Liangpunsakul S, Christensen JE, Shah VH, Kamath PS, Gores GJ, Walker S, Comerford M, Katz B, Borst A, et al. The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis. Hepatology. 2018 Apr;67:1284–302. doi:10.1002/hep.v67.4.
- Mutlu EA, Gillevet PM, Rangwala H, Sikaroodi M, Naqvi A, Engen PA, Kwasny M, Lau CK, Keshavarzian A. Colonic microbiome is altered in alcoholism. Am J Physiol Gastrointest Liver Physiol. 2012 May;302:G966–78. doi:10.1152/ajpgi.00380.2011.
- Tsuruya A, Kuwahara A, Saito Y, Yamaguchi H, Tsubo T, Suga S, Inai M, Aoki Y, Takahashi S, Tsutsumi E, et al. Ecophysiological consequences of alcoholism on human gut microbiota: implications for ethanol-related pathogenesis of colon cancer. Sci Rep. 2016 Jun;6:27923. doi:10.1038/srep27923.
- Dubinkina VB, Tyakht AV, Odintsova VY, Yarygin KS, Kovarsky BA, Pavlenko AV, Ischenko DS, Popenko AS, Alexeev DG, Taraskina AY, et al. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease. Microbiome. 2017 Oct;5:141. doi:10.1186/s40168-017-0359-2.
- Tuomisto S, Pessi T, Collin P, Vuento R, Aittoniemi J, Karhunen PJ. Changes in gut bacterial populations and their translocation into liver and ascites in alcoholic liver cirrhotics. BMC Gastroenterol. 14:40. 2014 Feb 24 [accessed 2019 Feb 25]. http://www.ncbi.nlm.nih.gov/pubmed/24564202.
- Bjørkhaug ST, Aanes H, Neupane SP, Bramness JG, Malvik S, Henriksen C, Skar V, Medhus AW, Valeur J. Characterization of gut microbiota composition and functions in patients with chronic alcohol overconsumption. Gut Microbes. 1–13. 2019 Mar 20 [accessed 2019 Aug 21]. http://www.ncbi.nlm.nih.gov/pubmed/30894059.
- Grander C, Adolph TE, Wieser V, Lowe P, Wrzosek L, Gyongyosi B, Ward DV, Grabherr F, Gerner RR, Pfister A, et al. Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease. Gut. 67:891–901. 2018 May [accessed 2019 Feb 25]. http://gut.bmj.com/lookup/doi/10.1136/gutjnl-2016-313432.
- Ciocan D, Voican CS, Wrzosek L, Hugot C, Rainteau D, Humbert L, Cassard A-M, Perlemuter G. Bile acid homeostasis and intestinal dysbiosis in alcoholic hepatitis. Aliment Pharmacol Ther. 2018 Nov;48:961–74. doi:10.1111/apt.14949.
- Engen PA, Green SJ, Voigt RM, Forsyth CB, Keshavarzian A. The gastrointestinal microbiome: alcohol effects on the composition of intestinal microbiota. Alcohol Res. 2015;37:223–36. [accessed 2018 Dec 20]. http://www.ncbi.nlm.nih.gov/pubmed/26695747.
- Leclercq S, Starkel P, Delzenne NM, de Timary P. The gut microbiota: A new target in the management of alcohol dependence? Alcohol. 2019 Feb;74:105–11. doi:10.1016/j.alcohol.2018.03.005.
- Shin N-R, Whon TW, Bae J-W. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 33:496–503. 2015 Sep 1 [accessed 2019 Mar 4]. https://www.sciencedirect.com/science/article/pii/S0167779915001390.
- Keshavarzian A, Farhadi A, Forsyth CB, Rangan J, Jakate S, Shaikh M, Banan A, Fields JZ. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. J Hepatol. 2009 Mar;50:538–47. doi:10.1016/j.jhep.2008.10.028.
- Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA. 110:9066–71. 2013 May 28 [accessed 2019 Mar 4]. http://www.pnas.org/cgi/doi/10.1073/pnas.1219451110.
- Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux -J-J, Blugeon S, Bridonneau C, Furet J-P, Corthier G, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 105:16731–36. 2008 Oct 28 [accessed 2019 Mar 4]. http://www.pnas.org/cgi/doi/10.1073/pnas.0804812105.
- Jiang S, Xie S, Lv D, Zhang Y, Deng J, Zeng L, Chen Y. A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression. Antonie Van Leeuwenhoek. 109:1389–96. 2016 Oct 18 [accessed 2019 Mar 4]. http://www.ncbi.nlm.nih.gov/pubmed/27431681.
- Elamin EE, Masclee AA, Dekker J, Pieters H-J, Jonkers DM. Short-chain fatty acids activate AMP-activated protein kinase and ameliorate ethanol-induced intestinal barrier dysfunction in Caco-2 cell monolayers. J Nutr. 2013 Dec;143:1872–81. doi:10.3945/jn.113.179549.
- Riordan SM, Williams R. The intestinal flora and bacterial infection in cirrhosis. J Hepatol. 45:744–57. 2006 Nov [accessed 2019 Mar 4]. http://www.ncbi.nlm.nih.gov/pubmed/16979776.
- Orrhage K, Nord CE. Bifidobacteria and lactobacilli in human health. Drugs Exp Clin Res. 2000;26:95–111. [accessed 2019 Mar 4]. http://www.ncbi.nlm.nih.gov/pubmed/10941602.
- Durbán A, Abellán JJ, Jiménez-Hernández N, Ponce M, Ponce J, Sala T, D’Auria G, Latorre A, Moya A. Assessing gut microbial diversity from feces and rectal mucosa. Microb Ecol. 61:123–33. 2011 Jan [accessed 2019 Aug 21]. http://www.ncbi.nlm.nih.gov/pubmed/20734040.
- Li G, Yang M, Zhou K, Zhang L, Tian L, Lv S, Jin Y, Qian W, Xiong H, Lin R, et al. Diversity of duodenal and rectal microbiota in biopsy tissues and luminal contents in healthy volunteers. J Microbiol Biotechnol. 25:1136–45. 2015 Jul [accessed 2019 Aug 21]. http://www.ncbi.nlm.nih.gov/pubmed/25737115.
- Jacobs JP, Dong TS, Agopian V, Lagishetty V, Sundaram V, Noureddin M, Ayoub WS, Durazo F, Benhammou J, Enayati P, et al. Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: the microbiome, microbial markers and liver disease study. Hepatol Res. 2018 Dec;48:1108–17. doi:10.1111/hepr.v48.13.
- Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L, Guo J, Le Chatelier E, Yao J, Wu L, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature. 513:59–64. 2014 Sep 23 [accessed 2019 Mar 4]. http://www.ncbi.nlm.nih.gov/pubmed/25079328.
- Acharya C, Sahingur SE, Bajaj JS. Microbiota, cirrhosis, and the emerging oral-gut-liver axis. JCI Insight. 2017 Oct 5;2. doi:10.1172/jci.insight.88864.
- Bajaj JS, Betrapally NS, Hylemon PB, Heuman DM, Daita K, White MB, Unser A, Thacker LR, Sanyal AJ, Kang DJ, et al. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy. Hepatology. 62:1260–71. 2015 Oct [accessed 2019 Aug 21]. http://www.ncbi.nlm.nih.gov/pubmed/25820757.
- Odamaki T, Kato K, Sugahara H, Hashikura N, Takahashi S, Xiao JZ, Abe F, Osawa R. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol. 2016 May 25;16:90.
- Filipp D, Brabec T, Vobořil M, Dobeš J. Enteric α-defensins on the verge of intestinal immune tolerance and inflammation. Semin Cell Dev Biol. 2018 Feb [accessed 2019 Mar 4]. http://www.ncbi.nlm.nih.gov/pubmed/29355606.
- Shukla PK, Meena AS, Rao V, Rao RG, Balazs L, Rao R. Human defensin-5 blocks ethanol and colitis-induced dysbiosis, tight junction disruption and inflammation in mouse intestine. Sci Rep. 2018 Nov;8:16241. doi:10.1038/s41598-018-34263-4.
- Yan AW, Fouts DE, Brandl J, Starkel P, Torralba M, Schott E, Tsukamoto H, E. Nelson K, A. Brenner D, Schnabl B. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology. 2011 Jan;53:96–105. doi:10.1002/hep.24018.
- Wang L, Fouts DE, Starkel P, Hartmann P, Chen P, Llorente C, DePew J, Moncera K, Ho S, Brenner D, et al. Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing mucosa-associated microbiota and preventing bacterial translocation. Cell Host Microbe. 2016 Feb;19:227–39. doi:10.1016/j.chom.2016.01.003.
- Hendrikx T, Duan Y, Wang Y, Oh J-H, Alexander LM, Huang W, Starkel P, Ho SB, Gao B, Fiehn O, et al. Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice. Gut. 2019 Aug;68(8):1504–15.
- Rendon JL, Li X, Akhtar S, Choudhry MA. Interleukin-22 modulates gut epithelial and immune barrier functions following acute alcohol exposure and burn injury. Shock. 39:11–18. 2013 Jan [accessed 2019 Mar 4]. http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00024382-201301000-00003.
- Dabard J, Bridonneau C, Phillipe C, Anglade P, Molle D, Nardi M, Ladire M, Girardin H, Marcille F, Gomez A, et al. Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces. Appl Environ Microbiol. 67:4111–18. 2001 Sep [accessed 2019 Mar 4]. http://www.ncbi.nlm.nih.gov/pubmed/11526013.
- Brandl K, Hartmann P, Jih LJ, Pizzo DP, Argemi J, Ventura-Cots M, Coulter S, Liddle C, Ling L, Rossi SJ, et al. Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis. J Hepatol. 69:396–405. 2018 Aug [accessed 2019 Mar 4]. https://linkinghub.elsevier.com/retrieve/pii/S0168827818319731.
- Wahlström A, Sayin SI, Marschall H-U, Bäckhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 24:41–50. 2016 Jul 12 [accessed 2019 Mar 4]. https://linkinghub.elsevier.com/retrieve/pii/S1550413116302236.
- Kurdi P, Kawanishi K, Mizutani K, Yokota A. Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria. J Bacteriol. 2006 Mar;188:1979–86. doi:10.1128/JB.00698-06.